Published in Oncotarget on October 24, 2016
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (2004) 19.19
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Regulation of iron metabolism by hepcidin. Annu Rev Nutr (2006) 3.96
Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia (2005) 2.41
Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med (2010) 1.94
Prostate cancer. Lancet (2015) 1.58
The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene (2008) 1.50
Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica (2010) 1.47
Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology (2011) 1.38
Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta (2012) 1.27
Ironing out cancer. Cancer Res (2011) 1.25
The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta (2013) 1.17
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat (2013) 1.07
Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review). Int J Mol Med (2007) 1.06
Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux. Blood (2010) 1.02
Iron deprivation in cancer--potential therapeutic implications. Nutrients (2013) 0.98
Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys (2011) 0.91
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell (2014) 0.91
Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4. FASEB J (2013) 0.90
Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells. Nutr Cancer (2007) 0.85
Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels. Biofactors (2015) 0.83
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities. Oncologist (2016) 0.82
Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1. Chem Res Toxicol (2016) 0.82
Disordered signaling governing ferroportin transcription favors breast cancer growth. Cell Signal (2014) 0.82
Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin. Haematologica (2012) 0.79
Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress. Oncogene (2014) 0.79
Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells. PLoS One (2014) 0.78
Pharmacological Targeting of the Hepcidin/Ferroportin Axis. Front Pharmacol (2016) 0.78
Decreased expression of ferroportin in prostate cancer. Oncol Lett (2015) 0.77
Increased nuclear factor erythroid 2-related factor 2 expression predicts worse prognosis of prostate cancer patients treated with radical prostatectomy. Hum Pathol (2014) 0.77
Hepcidin and ferroportin expression in breast cancer tissue and serum and their relationship with anemia. Curr Oncol (2016) 0.77
A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition. Mol Cancer Ther (2016) 0.77
Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells. Nutr Cancer (2016) 0.77
Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells. Toxicol Appl Pharmacol (2016) 0.77